revolugen limited Company Information
Company Number
03518866
Next Accounts
Sep 2025
Shareholders
trustees of the saints qnups
executors of estate of stephen john minter
View AllGroup Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
33 high street, ascot, berkshire, SL5 7HG
Website
www.revolugen.co.ukrevolugen limited Estimated Valuation
Pomanda estimates the enterprise value of REVOLUGEN LIMITED at £21.2k based on a Turnover of £11.7k and 1.81x industry multiple (adjusted for size and gross margin).
revolugen limited Estimated Valuation
Pomanda estimates the enterprise value of REVOLUGEN LIMITED at £0 based on an EBITDA of £-1.1m and a 7.14x industry multiple (adjusted for size and gross margin).
revolugen limited Estimated Valuation
Pomanda estimates the enterprise value of REVOLUGEN LIMITED at £0 based on Net Assets of £-1.1m and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Revolugen Limited Overview
Revolugen Limited is a live company located in berkshire, SL5 7HG with a Companies House number of 03518866. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in February 1998, it's largest shareholder is trustees of the saints qnups with a 15.9% stake. Revolugen Limited is a mature, micro sized company, Pomanda has estimated its turnover at £11.7k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Revolugen Limited Health Check
Pomanda's financial health check has awarded Revolugen Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs


2 Strong

0 Regular

7 Weak

Size
annual sales of £11.7k, make it smaller than the average company (£4.4m)
£11.7k - Revolugen Limited
£4.4m - Industry AVG

Growth
3 year (CAGR) sales growth of -10%, show it is growing at a slower rate (13.5%)
-10% - Revolugen Limited
13.5% - Industry AVG

Production
with a gross margin of 100%, this company has a lower cost of product (54.2%)
100% - Revolugen Limited
54.2% - Industry AVG

Profitability
an operating margin of -10229.1% make it less profitable than the average company (-4.7%)
-10229.1% - Revolugen Limited
-4.7% - Industry AVG

Employees
with 15 employees, this is below the industry average (54)
15 - Revolugen Limited
54 - Industry AVG

Pay Structure
on an average salary of £56.8k, the company has a lower pay structure (£83.1k)
£56.8k - Revolugen Limited
£83.1k - Industry AVG

Efficiency
resulting in sales per employee of £778.2, this is less efficient (£131.4k)
£778.2 - Revolugen Limited
£131.4k - Industry AVG

Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Revolugen Limited
- - Industry AVG

Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Revolugen Limited
- - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Revolugen Limited
- - Industry AVG

Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (30 weeks)
0 weeks - Revolugen Limited
30 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 600%, this is a higher level of debt than the average (52.7%)
600% - Revolugen Limited
52.7% - Industry AVG
REVOLUGEN LIMITED financials

Revolugen Limited's latest turnover from December 2023 is £11.7 thousand and the company has net assets of -£1.1 million. According to their latest financial statements, Revolugen Limited has 15 employees and maintains cash reserves of £5 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 11,673 | 28,318 | 20,991 | 16,244 | 48,207 | ||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 1,320 | 2,136 | 3,158 | 21,240 | |||||||||||
Gross Profit | 11,673 | 26,998 | 18,855 | 13,086 | 26,967 | ||||||||||
Admin Expenses | 1,205,712 | 2,140,246 | 1,422,047 | 1,967,524 | 1,516,105 | 4,147,382 | |||||||||
Operating Profit | -1,194,039 | -2,113,248 | -1,403,192 | -1,954,438 | -1,489,138 | -4,147,382 | -1,360,287 | -1,111,048 | -1,019,559 | -216,841 | |||||
Interest Payable | 14,077 | 2,610 | 3,190 | 2,766 | 3,159 | 5,249 | 7,998 | 13,556 | 3,432 | ||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | -1,208,116 | -2,115,858 | -1,406,382 | -1,957,204 | -1,492,297 | -4,152,631 | -1,368,285 | -1,124,604 | -1,027,592 | -220,273 | |||||
Tax | 74,778 | 146,092 | 150,612 | 159,472 | 156,000 | 168,189 | 138,118 | 119,555 | 98,404 | 27,167 | |||||
Profit After Tax | -1,133,338 | -1,969,766 | -1,255,770 | -1,797,732 | -1,336,297 | -3,984,442 | -1,230,167 | -1,005,049 | -929,188 | -193,106 | |||||
Dividends Paid | |||||||||||||||
Retained Profit | -1,133,338 | -1,969,766 | -1,255,770 | -1,797,732 | -1,336,297 | -3,984,442 | -1,230,167 | -1,005,049 | -929,188 | -193,106 | |||||
Employee Costs | 851,293 | 1,699,126 | 813,907 | 979,645 | 716,236 | 2,312,801 | 234,129 | 253,921 | 229,729 | ||||||
Number Of Employees | 15 | 16 | 12 | 12 | 12 | 12 | 4 | 4 | 2 | ||||||
EBITDA* | -1,128,985 | -2,031,662 | -1,352,324 | -1,913,784 | -1,457,936 | -3,102,163 | -1,341,982 | -1,052,864 | -1,019,559 | -167,915 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 94,620 | 145,505 | 261,120 | 245,140 | 79,415 | 66,890 | 18,037 | 32,636 | 68,193 | 131,175 | 175,001 | 130,245 | 768 | ||
Intangible Assets | 20,073 | 34,242 | |||||||||||||
Investments & Other | 79,832 | 79,832 | 79,832 | ||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 114,693 | 179,747 | 261,120 | 245,140 | 79,415 | 66,890 | 18,037 | 32,636 | 68,193 | 131,175 | 175,001 | 130,245 | 80,600 | 79,832 | 79,832 |
Stock & work in progress | 1,711 | ||||||||||||||
Trade Debtors | 145,000 | 222,951 | 103,396 | 31,784 | 33,386 | 153,057 | 153,457 | 147,157 | |||||||
Group Debtors | |||||||||||||||
Misc Debtors | 107,054 | 183,915 | 237,258 | 245,778 | 374,383 | 369,445 | 196,313 | 262,280 | 84,393 | 75,677 | |||||
Cash | 4,983 | 51,044 | 37,209 | 690,433 | 204,398 | 127,586 | 1,124 | 33,009 | 22,506 | 56,366 | 8,373 | ||||
misc current assets | 3,754 | ||||||||||||||
total current assets | 112,037 | 234,959 | 274,467 | 936,211 | 578,781 | 497,031 | 342,437 | 518,240 | 210,295 | 135,797 | 31,784 | 41,759 | 154,768 | 153,457 | 147,157 |
total assets | 226,730 | 414,706 | 535,587 | 1,181,351 | 658,196 | 563,921 | 360,474 | 550,876 | 278,488 | 266,972 | 206,785 | 172,004 | 235,368 | 233,289 | 226,989 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 92,254 | 58,096 | 27,812 | 76,672 | 209,984 | 54,189 | 192,924 | 50,461 | 55,000 | 15,380 | 218,352 | 131,356 | 72,557 | 49,539 | 36,250 |
Group/Directors Accounts | |||||||||||||||
other short term finances | 315,905 | ||||||||||||||
hp & lease commitments | 15,271 | 14,543 | 13,851 | 13,191 | 21,913 | ||||||||||
other current liabilities | 1,246,236 | 486,650 | 62,477 | 73,124 | 76,364 | 71,001 | 235,094 | 79,228 | 191,428 | 6,265 | |||||
total current liabilities | 1,353,761 | 559,289 | 104,140 | 162,987 | 308,261 | 125,190 | 428,018 | 129,689 | 562,333 | 21,645 | 218,352 | 131,356 | 72,557 | 49,539 | 36,250 |
loans | 13,172 | 43,714 | 72,800 | 100,502 | 21,290 | ||||||||||
hp & lease commitments | 6,586 | 21,857 | 36,400 | 50,251 | 10,645 | ||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | 12,500 | 12,500 | 12,500 | ||||||||||||
provisions | |||||||||||||||
total long term liabilities | 6,586 | 21,857 | 36,400 | 50,251 | 10,645 | 12,500 | 12,500 | 12,500 | |||||||
total liabilities | 1,360,347 | 581,146 | 140,540 | 213,238 | 318,906 | 125,190 | 428,018 | 129,689 | 562,333 | 21,645 | 218,352 | 131,356 | 85,057 | 62,039 | 48,750 |
net assets | -1,133,617 | -166,440 | 395,047 | 968,113 | 339,290 | 438,731 | -67,544 | 421,187 | -283,845 | 245,327 | -11,567 | 40,648 | 150,311 | 171,250 | 178,239 |
total shareholders funds | -1,133,617 | -166,440 | 395,047 | 968,113 | 339,290 | 438,731 | -67,544 | 421,187 | -283,845 | 245,327 | -11,567 | 40,648 | 150,311 | 171,250 | 178,239 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | -1,194,039 | -2,113,248 | -1,403,192 | -1,954,438 | -1,489,138 | -4,147,382 | -1,360,287 | -1,111,048 | -1,019,559 | -216,841 | |||||
Depreciation | 65,054 | 81,586 | 50,868 | 40,654 | 31,202 | 18,423 | 18,305 | 58,184 | 48,926 | 48,226 | 32,392 | 192 | 411 | ||
Amortisation | 1,026,796 | ||||||||||||||
Tax | 74,778 | 146,092 | 150,612 | 159,472 | 156,000 | 168,189 | 138,118 | 119,555 | 98,404 | 27,167 | |||||
Stock | -1,711 | 1,711 | |||||||||||||
Debtors | -76,861 | -53,343 | -8,520 | -128,605 | 4,938 | 28,132 | -143,918 | 297,442 | 112,112 | 43,893 | -1,602 | -119,671 | -400 | 6,300 | 147,157 |
Creditors | 34,158 | 30,284 | -48,860 | -133,312 | 155,795 | -138,735 | 142,463 | -4,539 | 39,620 | -202,972 | 86,996 | 58,799 | 23,018 | 13,289 | 36,250 |
Accruals and Deferred Income | 759,586 | 424,173 | -10,647 | -3,240 | 5,363 | -164,093 | 155,866 | -112,200 | 185,163 | 6,265 | |||||
Deferred Taxes & Provisions | |||||||||||||||
Cash flow from operations | -183,602 | -1,377,770 | -1,252,699 | -1,762,259 | -1,145,716 | -3,264,934 | -761,617 | -1,347,490 | -808,484 | -381,348 | |||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | -79,832 | 79,832 | |||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | |||||||||||||||
Other Short Term Loans | -315,905 | 315,905 | |||||||||||||
Long term loans | -30,542 | -29,086 | -27,702 | 79,212 | 21,290 | ||||||||||
Hire Purchase and Lease Commitments | -14,543 | -13,851 | -13,191 | 30,884 | 32,558 | ||||||||||
other long term liabilities | -12,500 | 12,500 | |||||||||||||
share issue | |||||||||||||||
interest | -14,077 | -2,610 | -3,190 | -2,766 | -3,159 | -5,249 | -7,998 | -13,556 | -3,432 | ||||||
cash flow from financing | 106,999 | 1,362,732 | 638,621 | 2,533,885 | 1,287,545 | 4,485,468 | 733,438 | 1,380,620 | 715,921 | 446,568 | |||||
cash and cash equivalents | |||||||||||||||
cash | -46,061 | 13,835 | -653,224 | 486,035 | 76,812 | 126,462 | -31,885 | 10,503 | -33,860 | 56,366 | -8,373 | 8,373 | |||
overdraft | |||||||||||||||
change in cash | -46,061 | 13,835 | -653,224 | 486,035 | 76,812 | 126,462 | -31,885 | 10,503 | -33,860 | 56,366 | -8,373 | 8,373 |
revolugen limited Credit Report and Business Information
Revolugen Limited Competitor Analysis

Perform a competitor analysis for revolugen limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in SL5 area or any other competitors across 12 key performance metrics.
revolugen limited Ownership
REVOLUGEN LIMITED group structure
Revolugen Limited has no subsidiary companies.
Ultimate parent company
REVOLUGEN LIMITED
03518866
revolugen limited directors
Revolugen Limited currently has 7 directors. The longest serving directors include Mr Adam Peake (Feb 2013) and Mr Daniel McPherson (Oct 2013).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Adam Peake | England | 61 years | Feb 2013 | - | Director |
Mr Daniel McPherson | Great Britain | 62 years | Oct 2013 | - | Director |
Mr Martin St.quinton | United Kingdom | 67 years | Jun 2016 | - | Director |
Mr Pieter Haitsma Mulier | 56 years | Jun 2016 | - | Director | |
Mr Erling Refsum | 70 years | Feb 2017 | - | Director | |
Dr Ann Simon | 71 years | Mar 2018 | - | Director | |
Mrs Susan Charles | 66 years | Feb 2022 | - | Director |
P&L
December 2023turnover
11.7k
-59%
operating profit
-1.2m
-43%
gross margin
100%
+4.89%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-1.1m
+5.81%
total assets
226.7k
-0.45%
cash
5k
-0.9%
net assets
Total assets minus all liabilities
revolugen limited company details
company number
03518866
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
February 1998
age
27
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
moorlodge biotech ventures limited (December 2016)
accountant
-
auditor
-
address
33 high street, ascot, berkshire, SL5 7HG
Bank
METRO BANK LIMITED
Legal Advisor
-
revolugen limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to revolugen limited.
revolugen limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for REVOLUGEN LIMITED. This can take several minutes, an email will notify you when this has completed.
revolugen limited Companies House Filings - See Documents
date | description | view/download |
---|